ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

STRO Sutro Biopharma Inc

3.46
-0.39 (-10.13%)
2024年6月15日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Sutro Biopharma Inc STRO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.39 -10.13% 3.46 13:00:00
始値 安値 高値 終値 前日終値
3.77 3.46 3.82 3.46 3.85
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1105:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1105:30EDGAR2Form 8-K - Current report
2024/6/1105:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1105:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1105:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1806:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/5/1405:34EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1405:30EDGAR2Form 8-K - Current report
2024/5/1405:30GLOBESutro Biopharma Reports First Quarter 2024 Financial..
2024/4/3021:00GLOBESutro Biopharma Announces Initiation of Randomized Portion..
2024/4/0219:18GLOBESutro Biopharma Announces Pricing of $75 Million..
2024/3/2605:30GLOBESutro Biopharma Reports Full Year 2023 Financial Results,..
2024/3/0806:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0806:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0806:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0806:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0506:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2806:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/1402:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1220:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1006:27EDGAR2Form 8-K - Current report
2024/2/1006:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/0706:05GLOBESutro Biopharma to Participate in Upcoming Investor..
2024/2/0106:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3007:14EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0821:31EDGAR2Form 8-K - Current report
2024/1/0506:05GLOBESutro Biopharma Highlights Potential Multi-Cancer..
2023/12/1506:05GLOBESutro Biopharma to Host Investor Webcast Highlighting..
2023/12/1206:05GLOBESutro Biopharma Announces New Positive Data from the..
2023/12/0506:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0506:05GLOBESutro Biopharma to Participate in the JMP Securities..
2023/11/2806:05EDGAR2Form 8-K - Current report
2023/11/2806:00GLOBEVaxcyte Exercises Option and Enters into Manufacturing..
2023/11/2214:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/2206:05EDGAR2Form 8-K - Current report
2023/11/2206:05GLOBESutro Biopharma Promotes Jane Chung to President and Chief..
2023/11/1407:18EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/1406:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1406:30EDGAR2Form 8-K - Current report
2023/11/1406:30GLOBESutro Biopharma Reports Third Quarter 2023 Financial..
2023/10/2217:25GLOBESutro Biopharma Announces Presentation of Data for..
2023/10/1705:05GLOBESutro Demonstrates Meaningful ADC Innovation with Five..
2023/10/0505:31EDGAR2Form 8-K - Current report
2023/9/2005:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2005:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/9/1921:00GLOBESutro Biopharma Appoints Dr. Hans-Peter Gerber as Chief..
2023/8/3021:00GLOBESutro Biopharma to Participate in Upcoming Investor..
2023/8/3005:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock